RHL · Est. MMXXV · Research-GradeLot · 2026-V · MMXXV

Precision peptides,
engineered.

RHL Research Peptides supplies high-purity research peptides to laboratories and qualified investigators. Every lot is independently tested, documented, and traceable.

Research use only≥98% PurityHPLC + MS verifiedCOA per lotLyophilized & sealedQualified researchers only
Research use only≥98% PurityHPLC + MS verifiedCOA per lotLyophilized & sealedQualified researchers only
01

≥98% Purity

02

HPLC + Mass Spec

03

COA per lot

04

US-Based Synthesis

"

We make peptides the way watchmakers make movements — one lot at a time, signed, sealed, and accountable to a single number.

RHL, founding principle
Catalog / 02

A focused range of reference compounds.

Synthesized for reproducible results in receptor binding, metabolic, and recovery research.

View all products
RHL
GHK-Cu
≥99.0%
Recovery

GHK-Cu

C₁₄H₂₄CuN₆O₄

Copper tripeptide reference compound for skin and tissue research assays.

Lyophilized50 mg
RHL
Semax
≥99.0%
Cognitive

Semax

C₃₇H₅₁N₉O₁₀S

Heptapeptide reference compound for neurochemistry and cognition research.

Lyophilized10 mg
RHL
Selank
≥99.0%
Cognitive

Selank

C₃₃H₅₇N₁₁O₉

Synthetic peptide reference compound for anxiolytic and neuropeptide research.

Lyophilized10 mg
RHL
MOTS-C
≥99.0%
Metabolic

MOTS-C

C₁₀₀H₁₅₃N₂₇O₂₂S₂

Mitochondrial-derived peptide reference compound for metabolic and longevity research.

Lyophilized10 mg
RHL
Tesamorelin
≥99.0%
Metabolic

Tesamorelin

C₂₂₁H₃₆₆N₇₂O₆₇S

GHRH analog reference compound for growth hormone and lipid metabolism research.

Lyophilized10 mg
RHL
DSIP
≥99.0%
Recovery

DSIP

C₃₅H₄₈N₁₀O₁₅

Delta sleep-inducing peptide reference compound for sleep and neuroendocrine research.

Lyophilized10 mg
RHL
Retatrutide
≥99.0%
Metabolic

Retatrutide

C₂₂₁H₃₄₃F₆N₅₁O₆₉

Triple agonist (GLP-1/GIP/glucagon) reference compound for metabolic and weight regulation research.

Lyophilized10 mg
RHL
BPC-157 + TB-500
≥99.0%
Recovery

BPC-157 + TB-500

C₆₂H₉₈N₁₆O₂₂ (BPC-157) / C₂₁₂H₃₅₀N₅₆O₇₈S (TB-500)

Synergistic blend of BPC-157 and TB-500 reference compounds for tissue repair and recovery research.

Lyophilized5 mg + 5 mg
RHL
N
≥99.0%
Longevity

NAD+

C₂₁H₂₇N₇O₁₄P₂

Nicotinamide adenine dinucleotide reference compound for cellular energy and longevity research.

Lyophilized1000 mg
RHL
Tirzepatide
≥99.0%
Metabolic

Tirzepatide

C₂₂₅H₃₄₈N₄₈O₆₈

Dual GLP-1/GIP receptor agonist reference compound for metabolic and glucose regulation research.

Lyophilized10 mg
RHL
CJC-1295 (No DAC) + Ipamorelin
≥99.0%
Recovery

CJC-1295 (No DAC) + Ipamorelin

C₁₅₂H₂₅₂N₄₄O₄₂ / C₃₈H₄₉N₉O₅

Synergistic GHRH analog and selective GH secretagogue blend for growth hormone pathway research.

Lyophilized5 mg + 5 mg
Quality / 03

Three standards we never compromise on.

I / Standard

High-purity synthesis

Solid-phase synthesized and verified to ≥98% purity by reverse-phase HPLC.

II / Standard

Independent testing

Mass spectrometry confirms identity. Lot-specific COAs available on request.

III / Standard

Documented chain of custody

Lyophilized, sealed, labeled with lot number, date, and storage requirements.

About / 04

Built for researchers who care about lot-to-lot consistency.

RHL was founded on a simple premise: research moves faster when materials are predictable. We work with established synthesis partners, document every step, and ship in the form factors a working lab actually needs.

Read our approach
FAQ / 05

Common questions.

Q.

Are these products intended for human use?

No. All RHL products are sold strictly for in-vitro laboratory research by qualified professionals.

Q.

Do you provide a Certificate of Analysis?

Yes. A lot-specific COA covering identity, purity, and mass is available for every product.

Q.

Who can purchase from RHL?

Sales are restricted to qualified researchers, academic institutions, and licensed laboratory facilities.

All questions

Working on something rigorous?

Send us your project specs. We'll respond with documentation, availability, and lead times for qualified inquiries.

Start an inquiry